Cristin Hubbard - EVP, Chief Commercial Officer at Biomarin Pharmaceutical Inc

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	19.4K	$1.49M	$77.05	May 20, 2024	Direct
Stock Option (Right to Buy Common Stock)	33.5K			May 20, 2024	Direct	Common Stock

Showing 1 to 2 of 2 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.